Search for: "Douglas v. Douglas"
Results 21 - 40
of 4,570
Sort by Relevance
|
Sort by Date
3 May 2024, 6:30 am
Verret (George Mason University), and Greg Lawrence (Lawrence Law), on Monday, April 29, 2024 Tags: Insider trading, Punawat, SEC, SEC v. [read post]
2 May 2024, 3:23 pm
Evidently Vanderpool’s principal attorney, Douglas Vanderpool, did not get the memo. [read post]
2 May 2024, 6:30 am
Connecticut and Stanley v. [read post]
30 Apr 2024, 10:28 am
Douglas Starr, in an article in Science, described IJOEH as having had a reputation for opposing “mercenary science,” which is interesting given that Egilman, many on his editorial board, and many of the authors who published in IJOEH were retained, paid expert witnesses in litigation. [read post]
29 Apr 2024, 7:58 am
In Bufkin v. [read post]
26 Apr 2024, 9:08 am
Douglas J. [read post]
26 Apr 2024, 7:00 am
Jay, Daniel Roeser, Douglas H. [read post]
26 Apr 2024, 3:51 am
The Douglas Elliman Defendants were the Halperins’ broker. [read post]
25 Apr 2024, 6:10 am
In Robey v. [read post]
25 Apr 2024, 6:10 am
In Robey v. [read post]
25 Apr 2024, 6:10 am
In Robey v. [read post]
24 Apr 2024, 11:27 am
Another multi-district litigation (MDL) has hit a jarring speed bump. [read post]
16 Apr 2024, 1:00 pm
No. 403 v. [read post]
15 Apr 2024, 10:00 pm
See Bart v. [read post]
13 Apr 2024, 3:33 pm
Prelude to Litigation Phenylpropanolamine (PPA) was a widely used direct α-adrenergic agonist used as a medication to control cold symptoms and to suppress appetite for weight loss.[1] In 1972, an over-the-counter (OTC) Advisory Review Panel considered the safety and efficacy of PPA-containing nasal decongestant medications, leading, in 1976, to a recommendation that the agency label these medications as “generally recognized as safe and effective. [read post]
12 Apr 2024, 10:23 am
In Vince v. [read post]
11 Apr 2024, 11:05 am
Lee Bailey, Carl Douglas, Peter Neyfeld and Gerald F. [read post]
10 Apr 2024, 9:01 pm
Rev. 965 (2017); Atherton v. [read post]
10 Apr 2024, 5:08 pm
Does 1-2 et. al. v. [read post]
8 Apr 2024, 10:08 am
The immunogenic mechanism had a few lines of potential support, with the most prominent at the time coming from the laboratories of Douglas Radford Shanklin, and his colleague, David L. [read post]
